Could a 5-day antiviral course ease long COVID? new study explores remdesivir.
NCT ID NCT05911906
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 33 times
Summary
This study looked at whether the antiviral drug remdesivir can reduce symptoms of Long COVID. 73 adults with confirmed Long COVID received the drug for five days and were monitored for about 8 weeks. The main goal was to see if this treatment approach is practical and tolerable for a future larger trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Derbyshire Community Health Services NHS Foundation Trust
Chesterfield, S42 7JE, United Kingdom
-
Royal Derby Hospital (UHDB)
Derby, D22 3NE, United Kingdom
-
University of Derby
Derby, Derby, DE22 1GB, United Kingdom
-
University of Exeter / Royal Devon University Healthcare NHS FT
Exeter, EX4 4PY, United Kingdom
Conditions
Explore the condition pages connected to this study.